# Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

> **NCT00062790** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 50 (—)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Dutasteride

## Key facts

- **NCT ID:** NCT00062790
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 50 (—)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062790, "Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels". Retrieved via MORVS 2026-10-13 from https://api.morvs.ai/clinical/NCT00062790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*